Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (2 active)

Company-led only

50 records in Main database · 39 strong · 47 status checked

Compare	Program	Company	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications
Add	Otarmeni by Regeneron	Regeneron Pharmaceuticals	Therapeutic	-	Gene Therapy	Approved	Approved	Details checkedStrong evidence	regulatory · Priority 1	99%	PediatricAdult+6	Hearing LossSensorineural Hearing Loss+3
Add	AK-OTOF by Eli Lilly and Akouos	Eli Lilly and Company	Therapeutic	-	Gene Therapy	Phase 2	Active	Details checkedStrong evidence	trial · Priority 1	95%	PediatricAdult+6	Hearing LossSensorineural Hearing Loss+3
Add	Cochlear Nucleus Nexa System	Cochlear	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	94%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss
Add	SENS-401 (Arazasetron) by Sensorion	Sensorion	Therapeutic	-	Small Molecule	Phase 2	Active	Details checkedStrong evidence	company · Priority 1	94%	AdultSudden / SSNHL+2	Hearing LossSensorineural Hearing Loss+2
Add	SENS-501 by Sensorion	Sensorion	Therapeutic	-	Gene Therapy	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 1	94%	PediatricCongenital+5	Hearing LossSensorineural Hearing Loss+3
Add	Envoy Medical Acclaim Cochlear Implant	Envoy Medical	Device	Cochlear Implants	Cochlear/Auditory Implant	Phase 2/3	Active	Details checkedStrong evidence	trial · Priority 1	93%	AdultPost-Lingual+1	Hearing LossSensorineural Hearing Loss
Add	MED-EL SYNCHRONY Cochlear Implant System	MED-EL	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 1	93%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss
Add	Cochlear Nucleus Profile Plus CI600 Series Implants	Cochlear	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	92%	PediatricAdult+3	Hearing LossSensorineural Hearing Loss+1
Add	Rincell-1 by Rinri Therapeutics	Rinri Therapeutics	Therapeutic	-	Cell Therapy	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 1	92%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+2
Add	Advanced Bionics HiRes Ultra 3D and Naída CI Marvel Platform	Advanced Bionics	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	91%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss
Add	MED-EL SYNCHRONY ABI	MED-EL	Device	Auditory BCI / Neurotech	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 1	86%	Profound	Hearing Loss
Add	Cochlear Osia System	Cochlear	Device	Bone Conduction & Middle Ear	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	96%	PediatricAdult+2	Hearing LossConductive Hearing Loss+2
Add	Cochlear Nucleus ABI541 Brainstem Implant	Cochlear	Device	Auditory BCI / Neurotech	BCI/Neurotech	Approved	Approved	Details checkedStrong evidence	regulatory · Priority 2	95%	AdultPost-Lingual+1	Hearing LossAuditory Neuropathy
Add	MED-EL VIBRANT SOUNDBRIDGE	MED-EL	Device	Bone Conduction & Middle Ear	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	95%	AdultUnilateral+2	Hearing LossSensorineural Hearing Loss+2
Add	ACOU085 by Acousia Therapeutics	Acousia Therapeutics GmbH	Therapeutic	-	Small Molecule	Phase 2	Active	Details checkedStrong evidence	company · Priority 2	93%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+2
Add	CIL001 (Paliroden) by Cilcare	Cilcare SAS	Therapeutic	-	Small Molecule	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 2	92%	AdultDiabetes+2	Hearing LossSensorineural Hearing Loss+2
Add	Cochlear Baha 7 Sound Processor	Cochlear	Device	Bone Conduction & Middle Ear	Bone Conduction / Middle-Ear Device	Marketed	Marketed	Details checkedStrong evidence	regulatory · Priority 2	92%	AdultPediatric+4	Hearing LossConductive Hearing Loss+2
Add	Cochlear Baha System	Cochlear	Device	Bone Conduction & Middle Ear	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	92%	PediatricAdult+4	Hearing LossConductive Hearing Loss+2
Add	NS101 by Neuracle Science	Neuracle Science Co., Ltd.	Therapeutic	-	Biologic	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 2	92%	AdultSudden / SSNHL+2	Hearing LossSensorineural Hearing Loss+2
Add	AK-antiVEGF by Eli Lilly and Akouos	Eli Lilly and Company	Therapeutic	-	Gene Therapy	Phase 1/2	Active	Details checkedStrong evidence	trial · Priority 2	90%	AdultUnilateral+2	Vestibular SchwannomaHearing Loss
Add	Cochlear Custom Sound Pro Fitting Software	Cochlear	Software/Neurotech	Fitting Software	Cochlear Implant Programming Software/Workflow	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	PediatricAdult+1	Hearing LossSensorineural Hearing Loss+1
Add	Cochlear Nucleus 8 Sound Processor	Cochlear	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss+1
Add	Cochlear Nucleus Kanso 3 Sound Processor	Cochlear	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	90%	PediatricAdult+3	Hearing LossSensorineural Hearing Loss+1
Add	Advanced Bionics Sky CI M Sound Processor	Advanced Bionics	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	89%	PediatricCochlear Implant+2	Hearing LossSensorineural Hearing Loss+1
Add	MED-EL MAESTRO 11 Fitting Software	MED-EL	Software/Neurotech	Fitting Software	Cochlear Implant Programming Software/Workflow	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	89%	PediatricAdult+1	Hearing LossSensorineural Hearing Loss+1
Add	MED-EL SYNCHRONY ABI Auditory Brainstem Implant	MED-EL	Device	Auditory BCI / Neurotech	BCI/Neurotech	Approved	Approved	Details checkedStrong evidence	company · Priority 2	89%	AdultPediatric+4	Hearing LossAuditory Neuropathy+1
Add	Advanced Bionics Target CI Fitting Software	Advanced Bionics	Software/Neurotech	Fitting Software	Cochlear Implant Programming Software/Workflow	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	88%	PediatricAdult+1	Hearing LossSensorineural Hearing Loss+1
Add	GJB2-GT by Sensorion	Sensorion	Therapeutic	-	Gene Therapy	Preclinical	Active	Details checkedStrong evidence	company · Priority 2	88%	CongenitalGenetic+1	Hearing LossSensorineural Hearing Loss+1
Add	MED-EL FLEX Series Cochlear Implant Electrode Arrays	MED-EL	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	88%	PediatricAdult+3	Hearing LossSensorineural Hearing Loss+1
Add	MED-EL RONDO 3 Audio Processor	MED-EL	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	88%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss+1
Add	Advanced Bionics HiFocus SlimJ and Mid-Scala Electrode Arrays	Advanced Bionics	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	87%	PediatricAdult+3	Hearing LossSensorineural Hearing Loss+1
Add	MED-EL SONNET 3 Audio Processor	MED-EL	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	87%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss+1
Add	ReSonance by Lineage Cell Therapeutics	Lineage Cell Therapeutics	Therapeutic	-	Cell Therapy	Preclinical	Active	Details checkedStrong evidence	company · Priority 2	87%	AdultAuditory Neuropathy	Hearing LossSensorineural Hearing Loss+1
Add	Nurotron Enduro Cochlear Implant System	Nurotron Biotechnology	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	86%	PediatricAdult+2	Hearing LossSensorineural Hearing Loss+1
Add	Cochlear CoPilot Rehabilitation App	Cochlear	Procedure/Rehab	Rehab & Procedures	Cochlear Implant Rehabilitation Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	85%	AdultCochlear Implant Users+4	Cochlear ImplantHearing Loss+1
Add	MED-EL BONEBRIDGE BCI 602	MED-EL	Device	Bone Conduction & Middle Ear	Cochlear/Auditory Implant	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	84%	PediatricAdult+2	Hearing LossConductive Hearing Loss+2
Add	MED-EL ReDi Rehabilitation App	MED-EL	Procedure/Rehab	Rehab & Procedures	Auditory Rehabilitation Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	84%	AdultPediatric+4	Cochlear ImplantHearing Loss+2
Add	Advanced Bionics HearingSuccess Rehab Portal	Advanced Bionics	Procedure/Rehab	Rehab & Procedures	Auditory Rehabilitation Software	Marketed	Marketed	Details checkedStrong evidence	company · Priority 2	83%	AdultPediatric+4	Cochlear ImplantHearing Loss+1
Add	AOK-1	Boehringer Ingelheim	Therapeutic	-	Regenerative Medicine	Preclinical	Active	Details checkedStrong evidence	company · Priority 2	82%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+2
Add	FX-322 by Frequency Therapeutics	Frequency Therapeutics	Therapeutic	-	Regenerative Medicine	Phase 2	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 1	96%	Adult	Hearing LossSensorineural Hearing Loss+2
Add	AM-111 by Auris Medical and Altamira	Altamira Therapeutics	Therapeutic	-	Biologic	Phase 3	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	95%	AdultSudden / SSNHL+1	Hearing LossSensorineural Hearing Loss+1
Add	FX-345 by Frequency Therapeutics	Frequency Therapeutics	Therapeutic	-	Regenerative Medicine	Phase 1	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	95%	Adult	Hearing LossSensorineural Hearing Loss
Add	OTO-413 by Otonomy	Otonomy	Therapeutic	-	Biologic	Phase 2	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	95%	AdultNoise-Induced	Hearing LossSensorineural Hearing Loss+2
Add	Oticon Medical Neuro System	Oticon Medical / Demant	Device	Cochlear Implants	Cochlear/Auditory Implant	Marketed	Discontinued	Details checkedStatus confirmedHistorical/discontinued	regulatory · Priority 2	94%	AdultPediatric+2	Hearing LossSensorineural Hearing Loss
Add	AM-101 by Auris Medical and Altamira	Altamira Therapeutics	Therapeutic	-	Small Molecule	Phase 3	Discontinued	Details checkedStatus confirmedHistorical/discontinued	trial · Priority 2	93%	AdultTinnitus	Tinnitus
Add	OTO-825 by Otonomy	Otonomy	Therapeutic	-	Gene Therapy	Preclinical	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	87%	PediatricCongenital+2	Hearing LossSensorineural Hearing Loss+1
Add	PIPE-505 by Pipeline Therapeutics	Contineum Therapeutics	Therapeutic	-	Small Molecule	Phase 1/2	Completed	Details checkedStatus confirmedHistorical/discontinued	trial · Priority 2	86%	Adult	Hearing LossSensorineural Hearing Loss+2
Add	Clearly Audiobooks by BioSpeech	BioSpeech	Procedure/Rehab	Rehab & Procedures	Behavioral/Rehabilitation	Interventional/NA	Completed	Details checkedClinical trial listing onlyHistorical/discontinued	registry+company · Priority 2	90%	AdultOlder Adult+4	Hearing Loss
Add	Cochlear CI632D dexamethasone-eluting electrode array	Cochlear	Device	Cochlear Implants	Cochlear/Auditory Implant	Interventional/NA	Active	Details checkedClinical trial listing only	registry · Priority 2	86%	AdultSensorineural+2	Hearing LossSensorineural Hearing Loss
Add	OTOV101N + OTOV101C by OtoVia Therapeutics	OtoVia Therapeutics	Therapeutic	-	Gene Therapy	Interventional/NA	Unknown	Details checkedClinical trial listing only	registry+publication · Priority 2	86%	PediatricAdult+3	Hearing LossSensorineural Hearing Loss+2

Otarmeni by Regeneron

Regeneron Pharmaceuticals · Gene Therapy · Approved

ApprovedTherapeuticStronger sources

Evidence

regulatory

Confidence

99%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss

Population

PediatricAdultCongenitalGenetic

Details

AK-OTOF by Eli Lilly and Akouos

Eli Lilly and Company · Gene Therapy · Phase 2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

95%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss

Population

PediatricAdultCongenitalGenetic

Details

Cochlear Nucleus Nexa System

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

94%

Indications

Hearing LossSensorineural Hearing Loss

Population

PediatricAdultBilateralProfound

Details

SENS-401 (Arazasetron) by Sensorion

Sensorion · Small Molecule · Phase 2

ActiveTherapeuticStronger sources

Evidence

company

Confidence

94%

Indications

Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossCisplatin-Induced Hearing Loss

Population

AdultSudden / SSNHLCisplatin OtotoxicityCochlear Implant

Details

SENS-501 by Sensorion

Sensorion · Gene Therapy · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

94%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing LossOTOF-Related Hearing Loss

Population

PediatricCongenitalGeneticOTOF / DFNB9

Details

Envoy Medical Acclaim Cochlear Implant

Envoy Medical · Cochlear/Auditory Implant · Phase 2/3

ActiveDeviceCochlear ImplantsStronger sources

Evidence

trial

Confidence

93%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultPost-LingualProfound

Details

MED-EL SYNCHRONY Cochlear Implant System

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

regulatory

Confidence

93%

Indications

Hearing LossSensorineural Hearing Loss

Population

PediatricAdultBilateralProfound

Details

Cochlear Nucleus Profile Plus CI600 Series Implants

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultCochlear ImplantImplantable Device

Details

Rincell-1 by Rinri Therapeutics

Rinri Therapeutics · Cell Therapy · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing LossAuditory Neuropathy

Population

AdultAge-RelatedAuditory Neuropathy

Details

Advanced Bionics HiRes Ultra 3D and Naída CI Marvel Platform

Advanced Bionics · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

91%

Indications

Hearing LossSensorineural Hearing Loss

Population

PediatricAdultBilateralProfound

Details

MED-EL SYNCHRONY ABI

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceAuditory BCI / NeurotechStronger sources

Evidence

company

Confidence

86%

Indications

Hearing Loss

Population

Profound

Details

Cochlear Osia System

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

regulatory

Confidence

96%

Indications

Hearing LossConductive Hearing LossMixed Hearing LossSensorineural Hearing Loss

Population

PediatricAdultUnilateralBilateral

Details

Cochlear Nucleus ABI541 Brainstem Implant

Cochlear · BCI/Neurotech · Approved

ApprovedDeviceAuditory BCI / NeurotechStronger sources

Evidence

regulatory

Confidence

95%

Indications

Hearing LossAuditory Neuropathy

Population

AdultPost-LingualProfound

Details

MED-EL VIBRANT SOUNDBRIDGE

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

regulatory

Confidence

95%

Indications

Hearing LossSensorineural Hearing LossConductive Hearing LossMixed Hearing Loss

Population

AdultUnilateralBilateralModerate to Severe

Details

ACOU085 by Acousia Therapeutics

Acousia Therapeutics GmbH · Small Molecule · Phase 2

ActiveTherapeuticStronger sources

Evidence

company

Confidence

93%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing LossCisplatin-Induced Hearing Loss

Population

AdultAge-RelatedCisplatin Ototoxicity

Details

CIL001 (Paliroden) by Cilcare

Cilcare SAS · Small Molecule · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy

Population

AdultDiabetesCochlear SynaptopathyHidden Hearing Loss

Details

Cochlear Baha 7 Sound Processor

Cochlear · Bone Conduction / Middle-Ear Device · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

regulatory

Confidence

92%

Indications

Hearing LossConductive Hearing LossMixed Hearing LossSingle-Sided Deafness

Population

AdultPediatricBone Conduction ProcessorSingle Sided Deafness

Details

Cochlear Baha System

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

company

Confidence

92%

Indications

Hearing LossConductive Hearing LossMixed Hearing LossSensorineural Hearing Loss

Population

PediatricAdultUnilateralBilateral

Details

NS101 by Neuracle Science

Neuracle Science Co., Ltd. · Biologic · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

92%

Indications

Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing LossCochlear Synaptopathy

Population

AdultSudden / SSNHLSensorineuralSalvage Therapy

Details

AK-antiVEGF by Eli Lilly and Akouos

Eli Lilly and Company · Gene Therapy · Phase 1/2

ActiveTherapeuticStronger sources

Evidence

trial

Confidence

90%

Indications

Vestibular SchwannomaHearing Loss

Population

AdultUnilateralVestibular SchwannomaHearing Adjacent

Details

Cochlear Custom Sound Pro Fitting Software

Cochlear · Cochlear Implant Programming Software/Workflow · Marketed

MarketedSoftware/NeurotechFitting SoftwareStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultPost Implant Programming

Details

Cochlear Nucleus 8 Sound Processor

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultPost Implant ProgrammingProfound

Details

Cochlear Nucleus Kanso 3 Sound Processor

Cochlear · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

90%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultCochlear ImplantPost Implant Programming

Details

Advanced Bionics Sky CI M Sound Processor

Advanced Bionics · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

89%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricCochlear ImplantProfoundBimodal

Details

MED-EL MAESTRO 11 Fitting Software

MED-EL · Cochlear Implant Programming Software/Workflow · Marketed

MarketedSoftware/NeurotechFitting SoftwareStronger sources

Evidence

company

Confidence

89%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultPost Implant Programming

Details

MED-EL SYNCHRONY ABI Auditory Brainstem Implant

MED-EL · BCI/Neurotech · Approved

ApprovedDeviceAuditory BCI / NeurotechStronger sources

Evidence

company

Confidence

89%

Indications

Hearing LossAuditory NeuropathyCongenital Hearing Loss

Population

AdultPediatricCongenitalProfound

Details

Advanced Bionics Target CI Fitting Software

Advanced Bionics · Cochlear Implant Programming Software/Workflow · Marketed

MarketedSoftware/NeurotechFitting SoftwareStronger sources

Evidence

company

Confidence

88%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultPost Implant Programming

Details

GJB2-GT by Sensorion

Sensorion · Gene Therapy · Preclinical

ActiveTherapeuticStronger sources

Evidence

company

Confidence

88%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing Loss

Population

CongenitalGeneticPre-Lingual

Details

MED-EL FLEX Series Cochlear Implant Electrode Arrays

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

88%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultCochlear ImplantImplantable Device

Details

MED-EL RONDO 3 Audio Processor

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

88%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultPost Implant ProgrammingProfound

Details

Advanced Bionics HiFocus SlimJ and Mid-Scala Electrode Arrays

Advanced Bionics · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

87%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultCochlear ImplantImplantable Device

Details

MED-EL SONNET 3 Audio Processor

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

87%

Indications

Hearing LossSensorineural Hearing LossCochlear Implant

Population

PediatricAdultPost Implant ProgrammingProfound

Details

ReSonance by Lineage Cell Therapeutics

Lineage Cell Therapeutics · Cell Therapy · Preclinical

ActiveTherapeuticStronger sources

Evidence

company

Confidence

87%

Indications

Hearing LossSensorineural Hearing LossAuditory Neuropathy

Population

AdultAuditory Neuropathy

Details

Nurotron Enduro Cochlear Implant System

Nurotron Biotechnology · Cochlear/Auditory Implant · Marketed

MarketedDeviceCochlear ImplantsStronger sources

Evidence

company

Confidence

86%

Indications

Hearing LossSensorineural Hearing LossDeafness

Population

PediatricAdultProfoundPost-Lingual

Details

Cochlear CoPilot Rehabilitation App

Cochlear · Cochlear Implant Rehabilitation Software · Marketed

MarketedProcedure/RehabRehab & ProceduresStronger sources

Evidence

company

Confidence

85%

Indications

Cochlear ImplantHearing LossCommunication Impairment

Population

AdultCochlear Implant UsersAuditory TrainingAural Rehabilitation

Details

MED-EL BONEBRIDGE BCI 602

MED-EL · Cochlear/Auditory Implant · Marketed

MarketedDeviceBone Conduction & Middle EarStronger sources

Evidence

company

Confidence

84%

Indications

Hearing LossConductive Hearing LossMixed Hearing LossSensorineural Hearing Loss

Population

PediatricAdultUnilateralBilateral

Details

MED-EL ReDi Rehabilitation App

MED-EL · Auditory Rehabilitation Software · Marketed

MarketedProcedure/RehabRehab & ProceduresStronger sources

Evidence

company

Confidence

84%

Indications

Cochlear ImplantHearing LossCommunication ImpairmentSpeech Impairment

Population

AdultPediatricCochlear Implant UsersAuditory Training

Details

Advanced Bionics HearingSuccess Rehab Portal

Advanced Bionics · Auditory Rehabilitation Software · Marketed

MarketedProcedure/RehabRehab & ProceduresStronger sources

Evidence

company

Confidence

83%

Indications

Cochlear ImplantHearing LossCommunication Impairment

Population

AdultPediatricCochlear Implant UsersHearing Aid Users

Details

AOK-1

Boehringer Ingelheim · Regenerative Medicine · Preclinical

ActiveTherapeuticStronger sources

Evidence

company

Confidence

82%

Indications

Hearing LossSensorineural Hearing LossAge-Related Hearing LossNoise-Induced Hearing Loss

Population

AdultAge-RelatedNoise-Induced

Details

FX-322 by Frequency Therapeutics

Frequency Therapeutics · Regenerative Medicine · Phase 2

DiscontinuedTherapeutic

Evidence

company

Confidence

96%

Indications

Hearing LossSensorineural Hearing LossNoise-Induced Hearing LossSudden Sensorineural Hearing Loss

Population

Adult

Details

AM-111 by Auris Medical and Altamira

Altamira Therapeutics · Biologic · Phase 3

DiscontinuedTherapeutic

Evidence

company

Confidence

95%

Indications

Hearing LossSensorineural Hearing LossSudden Sensorineural Hearing Loss

Population

AdultSudden / SSNHLProfound

Details

FX-345 by Frequency Therapeutics

Frequency Therapeutics · Regenerative Medicine · Phase 1

DiscontinuedTherapeutic

Evidence

company

Confidence

95%

Indications

Hearing LossSensorineural Hearing Loss

Population

Adult

Details

OTO-413 by Otonomy

Otonomy · Biologic · Phase 2

DiscontinuedTherapeutic

Evidence

company

Confidence

95%

Indications

Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy

Population

AdultNoise-Induced

Details

Oticon Medical Neuro System

Oticon Medical / Demant · Cochlear/Auditory Implant · Marketed

DiscontinuedDeviceCochlear Implants

Evidence

regulatory

Confidence

94%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultPediatricBilateralProfound

Details

AM-101 by Auris Medical and Altamira

Altamira Therapeutics · Small Molecule · Phase 3

DiscontinuedTherapeutic

Evidence

trial

Confidence

93%

Indications

Tinnitus

Population

AdultTinnitus

Details

OTO-825 by Otonomy

Otonomy · Gene Therapy · Preclinical

DiscontinuedTherapeutic

Evidence

company

Confidence

87%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing Loss

Population

PediatricCongenitalGeneticPre-Lingual

Details

PIPE-505 by Pipeline Therapeutics

Contineum Therapeutics · Small Molecule · Phase 1/2

CompletedTherapeutic

Evidence

trial

Confidence

86%

Indications

Hearing LossSensorineural Hearing LossHidden Hearing LossCochlear Synaptopathy

Population

Adult

Details

Clearly Audiobooks by BioSpeech

BioSpeech · Behavioral/Rehabilitation · Interventional/NA

CompletedProcedure/RehabRehab & Procedures

Evidence

registry+company

Confidence

90%

Indications

Hearing Loss

Population

AdultOlder AdultPediatricHearing Aid User

Details

Cochlear CI632D dexamethasone-eluting electrode array

Cochlear · Cochlear/Auditory Implant · Interventional/NA

ActiveDeviceCochlear Implants

Evidence

registry

Confidence

86%

Indications

Hearing LossSensorineural Hearing Loss

Population

AdultSensorineuralCochlear ImplantImplantable Device

Details

OTOV101N + OTOV101C by OtoVia Therapeutics

OtoVia Therapeutics · Gene Therapy · Interventional/NA

UnknownTherapeutic

Evidence

registry+publication

Confidence

86%

Indications

Hearing LossSensorineural Hearing LossGenetic Hearing LossDFNB9

Population

PediatricAdultGeneticDfnb9

Details